Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment

MLA

Fang-fang Mou, et al. “Guanxin Danshen Formulation Improved the Effect of Mesenchymal Stem Cells Transplantation for the Treatment of Myocardial Infarction Probably via Enhancing the Engraftment.” Life Sciences, vol. 233, June 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f9749eec811adcc01e1ccabc947cafcb&authtype=sso&custid=ns315887.

APA

Fang-fang Mou, Zhi-rong Luo, Qiang-Li Wang, Xiao-jing Han, Chong-bin Liu, Hai-dong Guo, & Han Li. (2019). Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment. Life Sciences, 233.

Chicago

Fang-fang Mou, Zhi-rong Luo, Qiang-Li Wang, Xiao-jing Han, Chong-bin Liu, Hai-dong Guo, and Han Li. 2019. “Guanxin Danshen Formulation Improved the Effect of Mesenchymal Stem Cells Transplantation for the Treatment of Myocardial Infarction Probably via Enhancing the Engraftment.” Life Sciences 233 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f9749eec811adcc01e1ccabc947cafcb&authtype=sso&custid=ns315887.